Percutaneous transforaminal endoscopic discectomy for adjoining section illness after lumbar fusion in aged sufferers over 65 years previous.
World Neurosurg. 2018 Feb 02;:
Authors: Gu G, Wang C, Gu X, Zhang H, Zhao Y, He S
PURPOSE: The purpose of the research was to judge the short-term efficacy and security of percutaneous transforaminal endoscopic discectomy (PTED) within the therapy of symptomatic ASD after lumbar fusion in aged sufferers over 65 years previous.
METHODS: We performed a retrospective research of aged sufferers over 65 years previous, who underwent PTED for ASD after lumbar fusion from January 2013 to September 2016. Demographics and perioperative scientific information have been collected from medical data. Apart from, MacNab classification, visible analog scale (VAS), Oswestry Incapacity Index (ODI) and Japanese Orthopaedics Affiliation Scores (JOA) in addition to short-form-36 scoring scale (SF-36) have been utilized to evaluate the efficacy of PTED.
RESULTS: A complete of 25 consecutive aged ASD sufferers over 65 years previous (11 male, 14 feminine; imply age 74.65±9.61 years) have been evaluated. The imply comply with up time was 37.14±11.60 months. 84.zero% of the sufferers (21/25) confirmed glorious or good scientific outcomes, 12.zero% (three/25) truthful and four.zero% (1/25) poor. As for problems, there have been 1 case of dural laceration, 1 case of postoperative dysesthesia (POD) and 1 case of recurrence. With respect to patient-reported outcomes, vital enhancements have been noticed postoperatively compared preoperatively in VAS (P<zero.05), ODI (P<zero.05) and JOA (P<zero.05) in addition to SF-36(P<zero.05).
CONCLUSION: PTED confirmed passable short-term efficacy and security within the administration of ASD after lumbar fusion in aged sufferers over 65 years previous. Due to this fact, PTED could be another choice for aged sufferers with ASD after lumbar fusion.
PMID: 29408425 [PubMed – as supplied by publisher]